Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective
AbstractAcute myocardial infarction, characterized by high morbidity and mortality, has now become a serious health hazard for human beings. Conventional surgical interventions to restore blood flow can rapidly relieve acute myocardial ischemia, but the ensuing myocardial ischemia-reperfusion injury...
Main Authors: | Shengnan Li, Fengmei Li, Yan Wang, Wenqun Li, Junyong Wu, Xiongbin Hu, Tiantian Tang, Xinyi Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2023.2298514 |
Similar Items
-
Platelet‐Like Fusogenic Liposome‐Mediated Targeting Delivery of miR‐21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia‐Reperfusion Injury
by: Haipeng Tan, et al.
Published: (2021-08-01) -
Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
by: Nancy Schanze, et al.
Published: (2019-06-01) -
Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries
by: Tianjiao Zhao, et al.
Published: (2022-01-01) -
Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia–reperfusion injury
by: Xueyi Weng, et al.
Published: (2022-10-01) -
Preclinical multi-target strategies for myocardial ischemia-reperfusion injury
by: Yuqing Li, et al.
Published: (2022-08-01)